Preliminary evaluation of the clinical utility of miRNA as neurobiological markers of TBI diagnosis and rTMS treatment responsiveness
Guardado en:
Autor principal: | Theresa Bender Pape |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1af478213ae049bc97cf111b2315066f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Customizing rTMS treatment targeting for co-occurring alcohol use disorder and mild traumatic brain injury using multi-modal neuroimaging data as neurobiological markers
por: Amy Herrold, et al.
Publicado: (2021) -
High Frequency rTMS Dosing for Smoking Cessation: Preliminary Findings
por: Christine Sheffer, et al.
Publicado: (2021) -
rTMS Dosing for Smoking Cessation: Pre-COVID Preliminary Results
por: Chrisitine Sheffer, et al.
Publicado: (2021) -
Combined rTMS/fMRI over the Motor and Prefrontal Brain Areas for Testing Therapeutic rTMS Protocols
por: Kai-Yen Chang, et al.
Publicado: (2021) -
Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression
por: Chen SJ, et al.
Publicado: (2013)